ChemoMetec A/S

ChemoMetec A/S

CHEMM · CO · Healthcare / Medical Devices

688.50DKK+3.50 (+0.51%)

Price History

Full chart

Market Stats

Previous Close685.00
Open684.00
Day Range684.00 – 699.50
52-Week Range235.20 – 804.00
Volume46.04K
Market Cap9.45B
P/E (TTM)47.54
Forward P/E0.00
EPS11.58
Dividend Yield1.35%
Beta1.39
50-Day Avg481.33
200-Day Avg444.40

About

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter NC-203, a high-precision cell counter designed to deliver complex cell samples; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Martin Helbo Behrens
  • Employees174
  • HeadquartersGydevang 43, Allerød, Denmark, 3450, Denmark
  • Websitehttps://chemometec.com

Leadership

  • Mr. Martin Helbo BehrensChief Executive Officer · b. 1992
  • Mr. Phillip Massie PriceChief Financial Officer · b. 1992
  • Mr. Bo Melholt NielsenChief Technology & Automation Officer
  • Mr. Christopher Runchel M.Sc., Ph.D.Chief Sales Officer
  • Mr. Søren KjærulffHead of R&D
  • Emil SondergaardChief Commercial Officer

Financials

Income Statement

Currency: DKK2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue8.65M11.45M14.60M22.31M44.82M32.05M32.61M37.23M39.20M41.40M45.23M61.24M85.23M90.33M112.69M175.51M214.10M281.13M428.39M444.40M407.87M495.57M511.06M
Growth (%)-+32.29%+27.59%+52.77%+100.91%-28.49%+1.73%+14.18%+5.29%+5.60%+9.26%+35.40%+39.18%+5.98%+24.75%+55.75%+21.99%+31.31%+52.38%+3.74%-8.22%+21.50%+3.12%
Cost of Revenue-2.18M1.47M3.75M3.51M3.09M7.55M3.24M4.24M4.43M4.59M9.01M12.93M10.13M13.21M16.89M20.18M27.78M44.14M49.01M40.27M30.06M25.06M
Gross Profit8.65M11.45M13.13M18.56M41.31M28.96M25.06M33.99M34.96M36.97M40.64M52.23M72.30M80.20M99.47M158.62M193.92M253.34M384.25M395.39M367.60M465.51M485.99M
Gross Margin100.00%100.00%89.93%83.19%92.17%90.36%76.84%91.29%89.19%89.30%89.86%85.28%84.83%88.78%88.28%90.38%90.57%90.12%89.70%88.97%90.13%93.93%95.10%
Operating Expense17.15M11.64M12.38M17.13M26.55M26.90M26.32M33.22M46.46M35.50M39.37M46.40M56.40M69.78M75.19M104.54M116.45M137.32M182.72M166.88M188.81M217.83M235.00M
Operating Income-8.50M-193.00K751.00K1.43M14.77M2.06M-1.26M773.00K-11.49M1.46M1.27M5.83M15.90M10.42M24.28M54.08M77.47M116.02M201.53M228.51M178.78M247.68M251.00M
Operating Margin-98.27%-1.69%5.14%6.41%32.94%6.43%-3.86%2.08%-29.32%3.53%2.81%9.52%18.65%11.53%21.55%30.81%36.18%41.27%47.04%51.42%43.83%49.98%49.11%
EBITDA-7.18M1.06M1.88M2.16M16.11M5.06M4.83M8.05M9.50M7.40M7.02M12.68M21.52M15.39M29.98M61.50M91.93M126.63M218.53M245.38M186.59M247.68M281.25M
EBITDA Margin-82.95%9.29%12.87%9.68%35.95%15.78%14.82%21.62%24.24%17.87%15.52%20.70%25.25%17.04%26.60%35.04%42.94%45.05%51.01%55.22%45.75%49.98%55.03%
Net Income-10.02M-2.35M4.09M843.00K13.23M4.60M-3.69M108.00K-9.87M346.00K1.15M7.95M10.48M7.49M18.21M41.84M59.16M88.35M159.47M178.67M136.28M186.41M201.84M
Net Income Margin-115.79%-20.57%28.03%3.78%29.52%14.35%-11.31%0.29%-25.17%0.84%2.54%12.98%12.30%8.29%16.16%23.84%27.63%31.43%37.23%40.20%33.41%37.61%39.49%
R&D-------1.99M20.18M7.72M7.96M9.21M4.50M3.80M3.69M5.69M6.48M6.49M7.23M7.16M8.39M10.37M15.41M
R&D as % of Total Revenue-------5.33%51.48%18.66%17.59%15.05%5.28%4.21%3.27%3.24%3.02%2.31%1.69%1.61%2.06%2.09%3.02%
Interest Expense776.00K1.08M1.08M294.00K224.00K550.00K289.00K239.00K349.00K174.00K122.00K495.00K1.21M1.07M887.00K716.00K1.19M918.00K1.52M1.09M183.00K624.00K392.00K
Interest Expense % of Total Revenue8.97%9.44%7.39%1.32%0.50%1.72%0.89%0.64%0.89%0.42%0.27%0.81%1.41%1.18%0.79%0.41%0.56%0.33%0.35%0.24%0.04%0.13%0.08%

Balance Sheet

Currency: DKK2004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets5.19M7.92M32.02M51.48M56.05M65.16M62.72M60.78M49.89M50.80M51.35M63.47M90.38M97.62M114.00M238.22M263.12M344.91M501.27M657.98M676.67M828.05M860.90M
Total Liabilities15.26M19.25M15.53M12.15M4.34M8.85M10.09M8.07M7.03M7.57M6.82M17.12M33.53M33.24M40.98M64.87M60.37M79.93M144.07M124.93M111.36M154.69M135.50M
Total Equity-10.06M-11.34M16.50M39.34M51.71M56.31M52.63M52.71M42.86M43.23M44.53M46.35M56.85M64.38M73.01M173.34M202.75M264.98M357.20M533.04M565.32M673.36M725.39M
Cash265.00K864.00K17.82M25.27M5.40M11.83M8.88M7.12M8.71M9.07M6.85M10.89M14.12M12.39M9.78M98.19M96.94M150.11M209.03M316.57M296.15M341.85M290.17M
Total Debt510.00K--2.80M-4.66M8.27M4.11M3.38M2.54M1.75M7.83M22.23M22.12M20.11M18.80M2.29M2.36M6.79M7.16M4.16M6.40M4.59M
Net Debt245.00K-864.00K-17.82M-22.47M-5.40M-7.16M-611.00K-3.01M-5.32M-6.52M-5.10M-3.06M8.11M9.73M10.33M-79.40M-94.65M-147.75M-202.23M-309.41M-291.99M-335.44M-285.58M

Cash Flow

Currency: DKK2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-283.00K486.00K-812.00K1.34M15.33M6.71M7.79M8.87M7.82M5.67M13.39M17.20M9.76M25.44M58.31M72.02M107.90M176.86M154.15M129.00M207.45M210.36M
Investing Cash Flow-1.68M-2.35M-8.21M-11.58M-13.57M-9.80M-8.84M-6.57M-6.64M-7.09M-9.30M-28.44M-10.28M-16.46M-27.06M-26.61M-24.68M-56.05M-40.83M-43.49M-85.52M-99.79M
Financing Cash Flow3.07M18.82M16.48M-9.63M4.66M142.00K-692.00K-729.00K-842.00K-787.00K-2.13M12.12M-355.00K-7.93M57.78M-46.26M-26.04M-69.01M-2.92M-105.72M-74.96M-161.58M
Capital Expenditure1.68M2.35M8.13M11.66M13.61M9.80M8.79M6.69M6.65M7.12M8.99M29.89M10.59M16.46M27.07M26.73M24.62M55.92M40.82M43.53M29.87M28.31M
Free Cash Flow-1.96M-1.86M-8.94M-10.32M1.72M-3.09M-1.00M2.18M1.17M-1.46M4.41M-12.69M-833.00K8.97M31.24M45.28M83.28M120.94M113.33M85.47M177.58M182.04M
Dividends Paid------------135.98M135.98M135.98M348.13M26.10M69.61M-104.42M69.60M123.30M
FCF to OCF693.64%-383.33%1101.23%-769.72%11.22%-46.04%-12.83%24.58%14.99%-25.67%32.91%-73.78%-8.54%35.28%53.58%62.88%77.18%68.38%73.52%66.26%85.60%86.54%
Dividend Paid to FCF-------------16324.61%1515.31%435.25%768.81%31.35%57.56%-122.16%39.19%67.73%

Earnings

Report DateFeb 10, 2017Sep 19, 2017Feb 9, 2018May 17, 2018Sep 18, 2018Nov 8, 2018Feb 8, 2019May 9, 2019Sep 17, 2019Nov 7, 2019Feb 7, 2020May 7, 2020Sep 16, 2020Nov 5, 2020Feb 5, 2021May 6, 2021Sep 15, 2021Nov 4, 2021Feb 8, 2022May 5, 2022Sep 15, 2022Nov 8, 2022Feb 9, 2023May 9, 2023Sep 13, 2023Nov 7, 2023Feb 5, 2024May 8, 2024Sep 11, 2024Nov 7, 2024Feb 5, 2025May 7, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Sep 10, 2026Feb 2, 2027
EPS Estimate---0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-3.233.122.742.773.182.852.883.543.17-0.963.984.693.66-1.15-
EPS Actual0.130.350.450.000.730.001.390.001.300.001.680.001.830.002.430.002.650.004.890.004.270.006.063.234.212.382.962.472.873.564.203.64------
Surprise-----------------------0.00%34.94%-13.14%6.86%-22.33%0.70%23.61%18.64%14.83%------
TimingPre-market-----------After-hoursPre-marketAfter-hours-After-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours--After-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-------After-hoursPre-market

Key Statistics & Ratios

Market Cap9.45B
Enterprise Value8.60B
Trailing P/E47.54
Forward P/E0.00
PEG Ratio0.00
Price / Sales18.49
Price / Book12.25
EPS11.58
Book Value41.94
Revenue (TTM)511.06M
Gross Profit (TTM)485.99M
EBITDA265.88M
Profit Margin39.49%
Operating Margin49.77%
Return on Equity28.56%
Return on Assets18.45%
Shares Outstanding17.16M
Shares Float16.48M
Beta1.39
Dividend Yield1.35%
Dividend Rate7.00
Payout Ratio60.34%

Dividends

20251×
7.00Oct 10, 2025
20241×
4.00Oct 11, 2024
20231×
6.00Oct 13, 2023
20211×
4.00Oct 15, 2021
20202×
1.50Oct 9, 202013.00Jan 14, 2020
20191×
7.50Oct 11, 2019